Top-News

ImmunoCellular Therapeutics News

Aktie
WKN:  A2DG0A ISIN:  US4525362046
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
35,20 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 13.03.2018

ImmunoCellular Therapeutics News

02.07.20 - PR Newswire
ImmunoCellular Therapeutics Announces Results of Special Meeting of Stockholders Held June 26, 2020
ImmunoCellular Therapeutics Announces Results of Special Meeting of Stockholders Held June 26, 2020 PR Newswire
16.10.19 - PR Newswire
ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit
ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit PR Newswire
17.10.18 - PR Newswire
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards PR Newswire
15.10.18 - PR Newswire
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants Management Team to Transition to Consulting Roles ...
13.08.18 - PR Newswire
ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results -Ongoing Exploration of Strategic Opportunities- -Continued ...
19.07.18 - PR Newswire
ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit
ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit Settlement Will Be Paid By Company's Insurance Carrier ...
14.05.18 - PR Newswire
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results -Continued Progress in Stem-​to-T-Cell Program- -Ongoing Exploration of Strategic Opportunities- PR ...
12.04.18 - PR Newswire
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-​to-T-Cell Research Immuno-​Oncology Program PR Newswire
26.03.18 - PR Newswire
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation PR Newswire
13.03.18 - PR Newswire
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results -Continued Progress in Stem-​to-T-Cell Program- -Strengthened Financial Condition- -...
07.03.18 - PR Newswire
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 PR Newswire
22.02.18 - PR Newswire
ImmunoCellular Therapeutics Announces Review of Strategic Alternatives
ImmunoCellular Therapeutics Announces Review of Strategic Alternatives PR Newswire
13.02.18 - PR Newswire
ImmunoCellular Therapeutics Announces Update on Financial Condition
ImmunoCellular Therapeutics Announces Update on Financial Condition Strengthened Financial Condition Supports Continued Advancement of Stem-​to-T-Cell Program PR Newswire
13.12.17 - PR Newswire
ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program
ImmunoCellular Therapeutics Achieves Key Milestone in Stem-​to-T-Cell Research Immuno-​Oncology Program Completes Important First Step toward Production of Unlimited Killer ...
22.11.17 - PR Newswire
ImmuncoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017
ImmuncoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 Live presentation will take place on December 7, 2017 at 9:30 a.m. PT ...
21.11.17 - PR Newswire
ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results
ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results -Continued Focus on Stem-​to-T-Cell Program- -Strengthened Financial Condition- -Conference Call ...
17.11.17 - PR Newswire
ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017
ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 PR Newswire
03.10.17 - PR Newswire
ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET
ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET Live presentation will take place on October 11, 2017 ...
13.09.17 - PR Newswire
ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance
ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance PR Newswire
23.08.17 - PR Newswire
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy - Near-Term Milestones Anticipated in Stem-​to-T-Cell ...

Newssuche

Videos

29.05.24 +17,26%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »